Menassie Taddese Appointed as Director at Xeris Biopharma
PUBLIC · XERSNov 02, 2026
Position
Director
Company
Xeris Biopharma Holdings
Menassie Taddese
ChicagoBiotechnologyHealth CareBiopharma
Description
Xeris Biopharma Holdings, Inc. appointed Menassie Taddese as a Class II director effective November 2, 2026. The appointment increases the Board size from eight to nine members, filling a newly created vacancy
Who to call at Xeris Biopharma Holdings, and when
A new leader at Xeris Biopharma Holdings brings new priorities and often new vendors. The first weeks are when they listen.
An alert the day Xeris Biopharma Holdings raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Xeris Biopharma Holdings, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Xeris Biopharma Holdings. With Fundz connected, it knows.
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Xeris Biopharma Holdings
Location
Chicago, Illinois, United States
About
Xeris Biopharma Holdings, Inc. is a growth-oriented biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products across a range of therapies.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Xeris Biopharma Holdings changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
ChicagoBiotechnologyHealth CareBiopharma